Forum Replies Created
-
AuthorPosts
-
Wow, now I realize what your info states, that you are married to someone with Hep C
Well, he won’t have Hep C for long, and If both ever come to NY City, I’d be happy to take you out for a drink to celebrate!
Thanks Tricia!
If you were not married and lived closer to me I would certainly like to take you out for dinner!
Hazel, Ariel, Tricia, I want to applaud your efforts and your thoughtfulness. It is truly refreshing and encouraging.
I think pressuring the establishment to show some compassion is a good thing. I pray you are successful.
But I am a cynical man, beyond all redemption
We have Bangladesh, and Twinvir, which Dr. Freeman has reported as an exact copy of Harvoni. I think the people at Incepta have enough third parties available to help with global distribution. Even if shipments from Bangladesh are blocked, it my be possible that shipments could be made from countries that Incepta can ship to, they distribute medications to many countries. Incepta is a large company that has over 600 products. And I believe they want to help.
Someone could post an ad on ebay about generic meds, and list the link to fixhepc. Make it an auction with a $1 million dollar minimum that is hidden and no one will win. But no one will bid anyway because they will read about fixhepc
Dr. Freeman, you’re not going to jail.
WebMD has your back
And you got a lot of exposure in US media besides this.
Look, a Twinvir video that includes info on how to buy it!
Hey Mike, is that your house in the pic you posted?
If so, that’s some sweet spread you have there
Hi Tricia,
And thanks to everyone who gave my crazy idea a thumbs up.
Tricia, what I proposed is really only a global version of what Dr. Freeman and GP2U offer now. I got an RX from GP2U, to buy Twinvir from a third party in Bangladesh and have it shipped to USA. The US government has no control of GP2U, Incepta cannot ship to USA, it had to come from a third party. But that was arranged because I paid for it. So likewise a foreign doctor who is paid by a hidden organization may be able to ship meds to Australia or elsewhere.
Unfortunately, this opportunity will only ever be available to people like us, who say “NO. There is a cure available and I am going to get it . F*** YOU” The system will not help you.
My GI specialist made an independent appeal to the government here 5 months ago, after I was denied 3 times by my insurance. The government has not responded. Meanwhile, I am undetected. Because of my efforts, and the help that was available.
I have faith that the wink and nod policy will stay in effect.
The customs man says “Look, I can’t believe they are trying to import these meds, as he allows it to continue down the conveyor for shipment It’s not about the law at this point. It’s about making them enforce it on a personal level.
I had not only my treatment sent to me from Bangladesh with an RX attached, but someone sent me some pills from Australia that were declared as “Liver Salts”, with a letter inside describing that they were Ledipasvir and Sofosbuvir tablets. With no RX attached. And I received them.
USA!
I had an idea that may be far fetched, but with some input and tweaking could prove effective in the long run.
At this point, the Courier delivery systems (FedEx, DHL, postal services) are still making deliveries of the meds.
Third parties who have access to these meds are still able to ship to many places.
What is needed is an RX from a doctor. But based on my experience in USA, a Tasmanian doctor was able to write an RX that I used to get a third party in Bangladesh to ship to me via DHL My package was in customs for 2 hours. That is the time it took them to get to it.
The problem is this: a doctor who will write an RX, and getting the word out, without having a commercial interest or profit motive, which then makes it illegal.
So what if a Non-profit was established – in Cyberspace, with a registration in the Cayman islands, or China, or whatever nonsensical place that will allow it without scrutiny — that took donations for advertising and operations, but was based in a server in China (that does not honor the patent) and used the money to advertise and advocate and arrange for RX’s in the event GP2U is no longer able to do so. I bet there are doctor’s in the world who will issue an RX for the right price. Utilizing the TOR browser, total anonymity of the participants in the organization can be kept secret. Officers in non-profits can pay themselves millions if the donors don’t object. Which could bring in sophisticated hacker types who can pull this off (ironically, perhaps criminal organizations doing good to profit against immoral companies).
And let’s not forget the Bangladeshi medications, notably Twinvir, unlicensed, as a developing country, Bangladshi pharmaceuticals are protected against patents until 2033 by the WHO charter. It’s why they were first to market, They don’t need no stinking license. These little rascals could turn up all over the place via third parties
Gilead could stop Indian generics now if thet wanted to, But are powerless against Bangladesh until 2033.
Just saying…Congratulations Thurl on SVR12
Glad to hear Twinvir worked for you! I hope I follow in your footsteps!
Here’s more bad news from a 2/16 press release that I feel addresses Dr. Freeman’s trial results:
Unless is modified, the TPP will exacerbate the global crisis of high drug prices. For example, the TPP will not allow national regulatory authorities to use existing clinical data demonstrating a pharmaceutical product’s safety and efficacy to authorize the sale of competitor products, even in the absence of patents. The additional monopoly protection provided for biologic drugs and vaccines will keep already very expensive products out of the hands of millions. The TPP would also force governments to extend existing patent monopolies beyond current 20-year terms at the request of pharmaceutical companies, and to redefine what type of medicine deserves a patent, including mandating the granting of new patents for modifications of existing medicines.
The only thing not mentioned was Dr. Freeman’s name! ick:' />
Perhaps an algorithm suppressed the words FREE MAN
The smoking gun:
Note the specific reference to Hepatitc C medications.
Mr. Narendra Modi
Honourable Prime Minister of India
Government of IndiaSmt. Nirmala Sitharaman
Honourable Minister of State for Commerce & Industry (Independent Charge)3rd February 2016
Dear Mr. Modi and Smt. Sitharaman, Médecins Sans Frontières/Doctors Without Borders (MSF) is an independent international medical humanitarian organization that delivers medical care to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare in nearly 70 countries. Our medical humanitarian work to provide health care to these populations requires constant access to affordable, quality generic medicines and vaccines, and patient-focused innovation. At the height of the AIDS crisis, MSF set up treatment projects and worked in close cooperation with several countries around the world – particularly India – on overcoming intellectual property barriers – to increase access to affordable HIV medicines. We are writing to you on the occasion of the signing of the Trans-Pacific Partnership Agreement (TPP) in New Zealand to draw the attention of the Indian government to our concerns regarding the potential negative consequences of this agreement on trade in affordable generic medicines among developing countries and particularly between India and ASEAN countries. The TPP is a regional trade agreement recently concluded by the United States and 11 other Pacific Rim countries (Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam). After years of negotiations without appropriate public input, TPP countries reached an agreement in October 2015, and the official text is only now publically available. The signing of the TPP is scheduled for February 4, 2016 in New Zealand, but the potential ratification and national implementation process is just starting. The TPP text confirms that if implemented, the agreement will be the most harmful trade pact ever for access to medicines. Intellectual Property Chapter in the TPP MSF’s analysis of the provisions in the TPP related to intellectual property (IP) reveal that they threaten to restrict access to affordable medicines for millions of people, treatment providers like MSF and Ministries of Health, and undermine the historic World Trade Organization (WTO) Ministerial Declaration on the TRIPS Agreement and Public Health (Doha Declaration).
The TPP contains stringent intellectual property (IP) provisions that will lengthen, strengthen and broaden pharmaceutical company monopolies beyond what is required under the WTO TRIPS Agreement. We have communicated our concerns about the IP Chapter of the TPP on numerous occasions to negotiating countries over the past four years. To reiterate, please find attached an analysis of the most harmful provisions.
The TPP will undermine and act as a permanent obstacle against reform The promise of the Doha Declaration is that the TRIPS Agreement can and should be interpreted and implemented in a manner supportive of WTO members’ right to protect public health and, in particular, to promote access to medicines for all. TRIPS-plus provisions in the TPP threaten to make it impossible for countries who sign the agreement to exercise the rights confirmed in Doha.
In fact, the TPP blocks countries that sign the agreement from doing precisely what India has done – amending their patent systems to include safeguards that will improve the quality of patent examination – and effectively address abusive patent ‘ever-greening’ practices that prolong patent monopolies. This will lock countries into paying excessive prices to multinational pharmaceutical companies for patented medicines, which undermines the right to health and national efforts to implement universal healthcare. MSF believes reform of the IP system is essential to overcoming the gap in access to medicines for millions of people around the world. Today, whether in response to the Ebola outbreak, the lack of new antibiotics to address TB and other drug-resistant infections, or the unaffordable price of $1000 per pill to treat hepatitis C in the US, there are numerous efforts underway to reform intellectual property rules while also introducing new approaches to incentivize R&D. The TPP will undermine and act as a permanent obstacle to such efforts. TPP in the region and the need to counter its expansion Lobbying efforts are now underway to actively encourage and pressure additional countries in the region — particularly India and ASEAN countries that did not participate in the negotiations—to join the TPP. Currently, Malaysia, Singapore and Vietnam from the ASEAN group are signing the TPP and starting national discussions on whether to ratify and implement the agreement. Indonesia and Thailand—middle-income countries that have championed TRIPS flexibilities and the Doha Declaration—have not participated in the negotiations, but have shown an interest in joining the TPP. It is imperative for countries in the region, including India, to lead an effort to counter the expansion of the TPP in the region and to promote the commitments enshrined in the Doha Declaration. Each of the new IP obligations in the TPP will limit access and trade in generic medicines, which has been one of the most reliable and powerful forces to reduce drug prices systematically, thereby making essential, life-saving medicines such as antiretrovirals (ARVs) for the treatment of HIV/AIDS more affordable for individuals and the health systems that serve them. As a medical humanitarian organization, we cannot accept the subordination of the health needs of our patients and millions of others to US trade interests. The US must not hamper the ability of countries in the region to fully implement the Doha Declaration. In order to ensure the protection of public health and the promotion of access to medicines, the TRIPS Agreement must be the ceiling for regional and bilateral trade agreements.
We thank you for your attention and are available for further discussions and information. Sincerely,
Dr. Manica Balasegaram
Executive Director,Rohit Malpani
Access Campaign Director Policy & AnalysisChina is now the only one not honoring the patent of
IMO, the availability of these meds through third party channels that exist now may remain unchanged, but the likelihood of policy changes at the national level of TPP countries is now 0%, especially given India’s patent reversal.
Score!!…..Goal!!!!
12 May 2016 at 2:55 am in reply to: India Patent Office approves Gilead’s hepatitis C drug patent #16990I agree, stay positive!
But in the mean time, advocate like hell!!
Gilead did not push so hard for this patent for no reason.
I just found some fine print in the article from MSF I posted
In regards to USA:
“The deal would raise our medicine prices, giving big pharmaceutical corporations new monopoly rights to keep lower cost generics drugs off the market. The TPP would roll back the modest reforms of the “May 2007” standards with respect to trade pact patent terms.”
The 2007 agreement allowed for access to foreign generic medications in developed countries. This could mean that the “3 month” supply rule has only been around since 2007, and is about to end hmy:
-
AuthorPosts